Xavier Ramnik 4
4 · MoonLake Immunotherapeutics · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Xavier Ramnik
Director
Transactions
- Award
Option to Buy
2025-06-05+6,682→ 6,682 totalExercise: $48.83Exp: 2035-06-05→ Class A ordinary shares, par value $0.0001 per share (6,682 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer.